Oryzon Genomics S.A.

€2.33As of Sun 8 Nov 2026, 12:00 UTC
BME:ORYHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR (2.42%)
Div yield —
ROE (2.08%)
Biotechnology
Beta (5Y) 0.42
PE TTM —
TSR TTM (34.12%)
Mkt cap €191.1M
ROIC (2.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.39
2.67%
127.53%
Hold 10|9|11|2|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.03
0.03
13.79%
25.65%
25.62%
12.38%
Revenue€M
14.37
15.11
14.77
14.67
(1.68%)
4.94%
5.39%
2.95%
Peers (US$214.6M)
Cap (US$)
PE
1.273B
16.58x
225.9M
—
115.7M
25.56x
Capital
TTM
5Y
10Y
Leveragex
2.667
0.048
0.041
EBIT/Intx
0.754
0.788
0.641
Own earn%
53.86
(64.31)
(51.25)
Sh yield%
22.17
8.88
13.23
Owners
Insiders/Inst%
5.85
51.34
Short interest%
0.90
SBC / revenue%
5.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
13